Abu Dhabi Public Health Center (ADPHC) has expanded its Reference Laboratory for Infectious Diseases (RLID-AD), strengthening the Emirate’s ability to detect, monitor, and respond to infectious diseases while reinforcing its leadership in global health emergency preparedness.
The expansion of the Reference Laboratory for Infectious Diseases, located at SEHA Sheikh Khalifa Medical City and operated by PureLab, part of PureHealth, aims to advance the laboratory’s molecular diagnostics and infectious disease testing capabilities, streamlining the entire process from sample reception to advanced analysis and genetic sequencing.
The upgraded facility significantly boosts testing capacity, enabling rapid diagnosis and effective surveillance during epidemics and pandemics while upholding the highest quality and biosafety standards.
The expansion also activates a BSL-3 mobile laboratory that delivers on-site testing in outbreak areas, strengthening rapid response, surveillance, and containment capabilities. Built to international standards, the unit reinforces Abu Dhabi’s laboratory biosafety framework and enhances overall epidemic preparedness.
The launch of the expansion of the Reference Laboratory for Infectious Diseases was marked by an event attended by senior representatives including Dr Rashed Obaid Al Suwaidi, General Director of ADPHC, Rashed Al Qubaisi, Group Chief Operating Officer at PureHealth, Arindam Haldar, Chief Executive Officer of PureLab, Dr Rawya Al Dhaheri, Executive Director of Operations at PureLab, and Bader Al Qubaisi, Chief Executive Officer of SEHA – Sheikh Khalifa Medical City (SKMC).
Dr. Rashed Obaid Al Suwaidi Director-General – ADPHC
“The expansion of our Reference Laboratory for Infectious Diseases represents a significant leap forward in strengthening Abu Dhabi’s health security. Through our investments in advanced laboratory infrastructure and biosafety capabilities, we are ensuring that the Emirate remains at the forefront of epidemic preparedness and response, driving innovation, fostering collaboration, and setting new standards for excellence in public health. In Abu Dhabi, we are reshaping the future of health by predicting risks, preventing disease, and taking proactive action to build a healthier, safer community for everyone. With the integration of advanced molecular testing and the establishment of a BSL-3 Unit, we are now equipped to deliver faster, more accurate diagnostics, reduce outsourcing dependence, and enable better resource management and evidence-based decision-making.”
The Reference Laboratory for Infectious Diseases is recognized by World Health Organization (WHO) as a National Influenza Centre, in addition to performing the testing for measles, rubella, and other pathogens. Notably, more than 50 percent of the laboratory’s workforce comprises of UAE national professionals, reflecting their strong technical expertise in advancing this vital field.
The expansion of the Reference Laboratory for Infectious Diseases forms part of Abu Dhabi’s long-term vision to strengthen its health system’s preparedness, resilience, and ability to respond effectively to infectious disease threats, ensuring the health and safety of all who live in and visit the emirate.
